Molecular targeting and pharmacogenomics in the management of advanced bladder cancer (Q35097985)

6 August 2017

1 reference

title

Molecular targeting and pharmacogenomics in the management of advanced bladder cancer (English)

1 reference

6 August 2017

1 reference

Derek Raghavan

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

97

1 reference

6 August 2017

issue

8 Suppl

1 reference

6 August 2017

page(s)

2083-2089

1 reference

Clonal analysis of a bladder cancer cell line: an experimental model of tumour heterogeneity

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Biology and management of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Molecular biology of urological tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

A, B, H antigens in transitional cell tumors of the urinary bladder.Correlation with the clinical course

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Transferrin receptor expression by human bladder transitional cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

p53 and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Overexpression of metallothionein confers resistance to anticancer drugs.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

P-glycoprotein expression in primary and metastatic transitional cell carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Pharmacogenetics and cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11281

7 January 2021

Identifiers

DOI

10.1002/CNCR.11281

1 reference

6 August 2017

1 reference